Physician profile
Maxwell Magee
NPI 1437686516
$15,930.98
in general payments reported to CMS, 2019-2025
21 companies · $4,181 in 2025
The $4,181 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $449 · 2022: $1,113 · 2023: $706 · 2024: $9,482 · 2025: $4,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $1,477 · Travel and Lodging: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $1,476.81 |
| Travel and Lodging | $891.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,491.85 | 2024-2025 | |
| Abbvie INC. | $602.82 | 2021-2023 | |
| Gynesonics, INC. | $315.01 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $264.81 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $237.31 | 2021-2024 | |
| Myovant Sciences INC. | $212.79 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $179.70 | 2023-2024 | Myfembree |
| Therapeuticsmd, INC. | $101.43 | 2021-2022 | |
| Organon LLC | $90.67 | 2022-2025 | Jada System, Nexplanon |
| Hologic Sales and Service, LLC | $85.74 | 2021-2023 | Third Wave, Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $72.28 | 2022-2023 | Slynd |
| Daiichi Sankyo INC. | $68.04 | 2021-2022 | |
| Agile Therapeutics, INC. | $40.67 | 2022 | |
| Astellas Pharma US INC | $36.34 | 2023 | Veozah |
| Coopersurgical, INC. | $29.31 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.57 | 2023 | |
| Biogen, INC. | $19.31 | 2024 | |
| Aspira Women'S Health INC | $18.38 | 2022 | |
| Applied Medical Resources Corporation | $17.80 | 2023 | |
| Evofem Biosciences, INC. | $13.51 | 2021 | |
| Avion Pharmaceuticals | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxwell Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.